10/23/2019
4:11 PM | Teva Pharmaceutical Industries (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/15/2019
5:42 AM | Drape Eric (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/02/2019
7:15 AM | Teva Pharmaceutical Industries (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/20/2019
6:19 AM | O'Grady Brendan P. (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2019
6:19 AM | Nazzi Gianfranco (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2019
6:17 AM | McClellan Michael James (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2019
6:12 AM | Griffin Deborah A (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2019
6:11 AM | Dethlefs Sven (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2019
6:10 AM | Daniell Richard (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2019
5:58 AM | Daniell Richard (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/07/2019
6:05 AM | Teva Pharmaceutical Industries (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/07/2019
6:00 AM | Teva Pharmaceutical Industries (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/13/2019
5:28 AM | Nisen Perry (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2019
5:26 AM | MIGNONE ROBERTO (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2019
5:26 AM | Halfon Jean Michel (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2019
5:18 AM | Crane Rosemary A (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2019
5:17 AM | Satchi-Fainaro Ronit (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2019
5:16 AM | Peres Nechemia Jacob (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2019
5:11 AM | LIEBERMAN GERALD M (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2019
5:08 AM | GOLDBERG MURRAY A (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2019
5:07 AM | Elstein Amir (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2019
5:02 AM | BARER SOL J (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2019
3:51 PM | Teva Pharmaceutical Industries (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/05/2019
6:02 AM | BARER SOL J (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2019
10:21 AM | BARER SOL J (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2019
11:15 AM | Teva Pharmaceutical Industries (Filer)
| Form SD
Specialized Disclosure Report | |
05/21/2019
5:38 AM | de Notaristefani Carlo (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2019
6:18 AM | de Notaristefani Carlo (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2019
6:13 AM | LIEBERMAN GERALD M (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2019
6:09 AM | Halfon Jean Michel (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2019
6:06 AM | Elstein Amir (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2019
6:00 AM | Crane Rosemary A (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2019
5:56 AM | BARER SOL J (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2019
3:02 PM | Teva Pharmaceutical Industries (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/02/2019
6:00 AM | Teva Pharmaceutical Industries (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/16/2019
3:15 PM | Teva Pharmaceutical Industries (Filer)
| Form DEFA14A
| |
04/16/2019
3:13 PM | Teva Pharmaceutical Industries (Filer)
| Form DEF 14A
| |
04/10/2019
7:01 AM | Teva Pharmaceutical Industries (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/19/2019
7:29 AM | O'Grady Brendan P. (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2019
7:17 AM | Nazzi Gianfranco (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2019
7:14 AM | Daniell Richard (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2019
7:11 AM | Stark David Matthew (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2019
7:08 AM | McClellan Michael James (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2019
7:06 AM | Griffin Deborah A (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2019
7:04 AM | Fridriksdottir Hafrun (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2019
7:02 AM | Dethlefs Sven (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2019
6:44 AM | Stark David Matthew (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2019
6:41 AM | O'Grady Brendan P. (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2019
6:36 AM | Nazzi Gianfranco (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2019
6:33 AM | Griffin Deborah A (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2019
6:31 AM | Dethlefs Sven (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2019
6:28 AM | Daniell Richard (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2019
6:30 AM | Stark David Matthew (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2019
6:28 AM | Schultz Kare (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2019
6:26 AM | Sabag Mark (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2019
6:24 AM | O'Grady Brendan P. (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2019
6:20 AM | Nazzi Gianfranco (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2019
6:18 AM | McClellan Michael James (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2019
6:15 AM | Griffin Deborah A (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2019
6:14 AM | Fridriksdottir Hafrun (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2019
6:11 AM | Dethlefs Sven (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2019
6:08 AM | de Notaristefani Carlo (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2019
6:05 AM | Daniell Richard (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2019
6:01 AM | Codner Iris Beck (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2019
7:20 AM | Nazzi Gianfranco (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2019
6:36 AM | O'Grady Brendan P. (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2019
6:28 AM | McClellan Michael James (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2019
6:23 AM | Griffin Deborah A (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2019
6:16 AM | Fridriksdottir Hafrun (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2019
6:10 AM | Dethlefs Sven (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2019
6:05 AM | Daniell Richard (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2019
7:35 AM | Teva Pharmaceutical Industries (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/19/2019
6:26 AM | Stark David Matthew (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2019
6:19 AM | Sabag Mark (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2019
6:11 AM | Fridriksdottir Hafrun (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2019
6:05 AM | de Notaristefani Carlo (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2019
5:58 AM | Codner Iris Beck (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2019
6:43 AM | de Notaristefani Carlo (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2019
6:40 AM | Codner Iris Beck (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2019
6:36 AM | Sabag Mark (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2019
6:00 AM | Teva Pharmaceutical Industries (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/28/2019
3:20 PM | FRANKLIN RESOURCES INC (Filed by)
Teva Pharmaceutical Industries (Subject)
| Form SC 13G/A
| |
01/03/2019
6:24 AM | Fridriksdottir Hafrun (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/14/2018
6:51 AM | Teva Pharmaceutical Industries (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/04/2018
3:24 PM | Teva Pharmaceutical Industries (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/04/2018
7:09 AM | Fridriksdottir Hafrun (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/03/2018
11:15 PM | Teva Pharmaceutical Industries (Filer)
| Form EFFECT
| |
11/26/2018
6:00 AM | Teva Pharmaceutical Industries (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2018
3:25 PM | Citibank,N.A./ADR (Filed by)
Teva Pharmaceutical Industries (Subject)
| Form F-6
Registration statement under the Securities Act of 1933 for depositary shares evidenced by American depositary receipts | |
11/07/2018
5:38 AM | McClellan Michael James (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2018
3:07 PM | Teva Pharmaceutical Industries (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/01/2018
6:02 AM | Teva Pharmaceutical Industries (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/09/2018
3:06 PM | Griffin Deborah A (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2018
3:10 PM | O'Grady Brendan P. (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2018
3:09 PM | Nazzi Gianfranco (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2018
3:08 PM | Griffin Deborah A (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2018
3:06 PM | Dethlefs Sven (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2018
3:04 PM | Daniell Richard (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2018
3:17 PM | Daniell Richard (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2018
3:09 PM | LIEBERMAN GERALD M (Reporting)
Teva Pharmaceutical Industries (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
